Literature DB >> 7887392

Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels.

F M Sacks1, J L Rouleau, L A Moye, M A Pfeffer, J W Warnica, J M Arnold, D T Nash, L E Brown, F Sestier, J Rutherford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7887392     DOI： 10.1016/s0002-9149(99)80631-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  3 in total

Review 1.  [Rationale for lipid therapy. Prevention or treatment of coronary heart disease?].

Authors:  E Windler; F U Beil
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

Review 2.  Pravastatin. A reappraisal of its pharmacological properties and clinical effectiveness in the management of coronary heart disease.

Authors:  M Haria; D McTavish
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

3.  Fractional Brownian motion and long term clinical trial recruitment.

Authors:  Qiang Zhang; Dejian Lai
Journal:  J Stat Plan Inference       Date:  2011-05-01       Impact factor: 1.111
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.